Quantification of clofarabine in urine and plasma by LC-MS/MS: suitable for PK study and TDM in pediatric patients with relapsed or refractory ALL
暂无分享,去创建一个
H. Chen | Xi Zhang | Pengfei Li | Jun Tai | Guangrun Li | Xinbei Jia | Weihang Tong | Ning Lei | Guangrun Li
[1] T. Brüning,et al. Nonylphenol exposure in 7-year-old Japanese children between 2012 and 2017- Estimation of daily intakes based on novel urinary metabolites. , 2022, Environment international.
[2] Y. Daali,et al. Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS/MS. , 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[4] C. Bereczki,et al. Improved LC-MS/MS method for the determination of 42 neurologically and metabolically important molecules in urine. , 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[5] A. Huitema,et al. Population pharmacokinetics of clofarabine for allogeneic hematopoietic cell transplantation in paediatric patients , 2021, British journal of clinical pharmacology.
[6] J. Kałużna-Czaplińska,et al. LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson’s Disease and Parkinsonian Syndromes Patients , 2020, Molecules.
[7] L. Mercolini,et al. Microsampling and LC-MS/MS for antidoping testing of glucocorticoids in urine. , 2020, Bioanalysis.
[8] E. C. Strickland,et al. A Dilute and Shoot LC-MS/MS Method for Antipsychotics in Urine. , 2019, Journal of analytical toxicology.
[9] V. Ivaturi,et al. Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[10] C. van Kesteren,et al. Simultaneous quantification of busulfan, clofarabine and F-ARA-A using isotope labelled standards and standard addition in plasma by LC-MS/MS for exposure monitoring in hematopoietic cell transplantation conditioning. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[11] G. Ehninger,et al. Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia , 2017, Leukemia & lymphoma.
[12] M. Bornhäuser,et al. Simultaneous determination of clofarabine and cytarabine in human plasma by LC-MS/MS. , 2016, Journal of pharmaceutical and biomedical analysis.
[13] F. Aweeka,et al. Simultaneous determination of fludarabine and clofarabine in human plasma by LC-MS/MS. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[14] P. O’Donnell,et al. Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant , 2014, Leukemia & lymphoma.
[15] J. Tolar,et al. Pharmacokinetics of Clofarabine in Patients With High‐Risk Inherited Metabolic Disorders Undergoing Brain‐Sparing Hematopoietic Cell Transplantation , 2011, Journal of clinical pharmacology.
[16] L. Silverman,et al. Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. , 2010, Blood.
[17] L. Silverman,et al. A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia , 2009, Leukemia.
[18] A. Pession,et al. Clofarabine, cyclophosphamide and etoposide as single‐course re‐induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia , 2009, British journal of haematology.
[19] Ming Liu,et al. Comparison of fast liquid chromatography/tandem mass spectrometric methods for simultaneous determination of cladribine and clofarabine in mouse plasma. , 2007, Journal of pharmaceutical and biomedical analysis.
[20] R. Kostiainen,et al. Atmospheric pressure photoionization-mass spectrometry and atmospheric pressure chemical ionization-mass spectrometry of neurotransmitters. , 2006, Journal of mass spectrometry : JMS.
[21] E. Estey,et al. Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias. , 2005, Blood.
[22] H. Kantarjian,et al. Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. , 2004, Blood.
[23] V. Gandhi,et al. Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats , 2002, Cancer Chemotherapy and Pharmacology.
[24] Walter A. Korfmacher,et al. Quantitative screening and matrix effect studies of drug discovery compounds in monkey plasma using fast-gradient liquid chromatography/tandem mass spectrometry. , 2001, Rapid communications in mass spectrometry : RCM.
[25] L. Burd,et al. Urine Methotrexate Concentration at 46-48 Hours Post-Treatment Reflects Methotrexate-Induced Acute Kidney Injury. , 2021, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.